Alkermes plc. Increase (Decrease) in Prepaid Expenses, Other
Alkermes plc. (ALKS) reported Increase (Decrease) in Prepaid Expenses, Other of $20.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-07-28
- Alkermes plc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $4.79M.
- Alkermes plc. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was $16.17M, a 1815.76% increase year-over-year.
- Alkermes plc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was -$3.84M.
- Alkermes plc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $19.15M.
- Alkermes plc. increase (decrease) in prepaid expenses, other for fiscal 2025 was -$852.00K.
- Alkermes plc. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$2.25M, a 106.47% decline from fiscal 2023.
- Alkermes plc. increase (decrease) in prepaid expenses, other for fiscal 2023 was $34.85M, a 554.04% increase from fiscal 2022.
- Alkermes plc. increase (decrease) in prepaid expenses, other for fiscal 2022 was $5.33M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $20.96M 10-Q · filed 2026-07-28 | $17.12M derived: sum of 3 quarters · filed 2026-07-28 | $36.27M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $16.17M 10-Q · filed 2026-05-05 | $12.33M derived: sum of 2 quarters · filed 2026-05-05 | $31.48M derived: sum of 3 quarters · filed 2026-05-05 | $14.47M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | -$3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.31M derived: sum of 2 quarters · filed 2026-02-25 | -$1.70M derived: sum of 3 quarters · filed 2026-07-28 | -$852.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $19.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.14M derived: sum of 2 quarters · filed 2026-07-28 | $2.98M 10-Q · filed 2025-10-28 | $2.62M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | -$17.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$16.16M 10-Q · filed 2026-07-28 | -$16.52M derived: sum of 3 quarters · filed 2026-07-28 | -$19.62M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $844.00K 10-Q · filed 2026-05-05 | $482.00K derived: sum of 2 quarters · filed 2026-05-05 | -$2.62M derived: sum of 3 quarters · filed 2026-05-05 | -$8.87M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.46M derived: sum of 2 quarters · filed 2026-02-25 | -$9.71M derived: sum of 3 quarters · filed 2026-02-25 | -$2.25M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$9.35M derived: sum of 2 quarters · filed 2025-10-28 | -$1.89M 10-Q · filed 2025-10-28 | $36.90M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.21M 10-Q · filed 2025-07-29 | $40.00M derived: sum of 3 quarters · filed 2026-02-25 | $35.28M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $7.46M 10-Q · filed 2025-05-01 | $46.26M derived: sum of 2 quarters · filed 2026-02-25 | $41.53M derived: sum of 3 quarters · filed 2026-02-25 | $38.61M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $38.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $34.07M derived: sum of 2 quarters · filed 2026-02-25 | $31.15M derived: sum of 3 quarters · filed 2026-02-25 | $34.85M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | -$7.64M derived: sum of 2 quarters · filed 2024-10-24 | -$3.95M 10-Q · filed 2024-10-24 | $3.25M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $774.00K 10-Q · filed 2024-07-24 | $7.97M derived: sum of 3 quarters · filed 2025-02-12 | $4.12M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $3.70M 10-Q · filed 2024-05-01 | $10.90M derived: sum of 2 quarters · filed 2025-02-12 | $7.04M derived: sum of 3 quarters · filed 2025-02-12 | -$6.33M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $3.34M derived: sum of 2 quarters · filed 2025-02-12 | -$10.02M derived: sum of 3 quarters · filed 2025-02-12 | $5.33M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$17.22M derived: sum of 2 quarters · filed 2023-10-25 | -$1.87M 10-Q · filed 2023-10-25 | -$14.86M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$13.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $1.99M 10-Q · filed 2023-07-26 | -$11.00M derived: sum of 3 quarters · filed 2024-02-21 | -$7.47M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $15.35M 10-Q · filed 2023-04-26 | $2.36M derived: sum of 2 quarters · filed 2024-02-21 | $5.90M derived: sum of 3 quarters · filed 2024-02-21 | -$12.94M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$9.45M derived: sum of 2 quarters · filed 2024-02-21 | -$28.29M derived: sum of 3 quarters · filed 2024-02-21 | -$11.48M 10-K · filed 2024-02-21 |
| 2021-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$15.30M derived: sum of 2 quarters · filed 2022-11-02 | $1.51M 10-Q · filed 2022-11-02 | $3.08M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$18.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$2.03M 10-Q · filed 2022-07-27 | -$454.00K derived: sum of 3 quarters · filed 2023-02-16 | $1.59M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $16.81M 10-Q · filed 2022-04-27 | $18.38M derived: sum of 2 quarters · filed 2023-02-16 | $20.43M derived: sum of 3 quarters · filed 2023-02-16 | $26.40M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $3.62M derived: sum of 2 quarters · filed 2023-02-16 | $9.59M derived: sum of 3 quarters · filed 2023-02-16 | -$4.02M 10-K · filed 2023-02-16 |
| 2020-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $8.02M derived: sum of 2 quarters · filed 2021-10-27 | -$5.60M 10-Q · filed 2021-10-27 | -$1.69M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $5.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$7.64M 10-Q · filed 2021-07-28 | -$3.74M derived: sum of 3 quarters · filed 2022-02-16 | -$5.12M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$13.62M 10-Q · filed 2021-04-28 | -$9.71M derived: sum of 2 quarters · filed 2022-02-16 | -$11.09M derived: sum of 3 quarters · filed 2022-02-16 | -$11.90M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $2.52M derived: sum of 2 quarters · filed 2022-02-16 | $1.72M derived: sum of 3 quarters · filed 2022-02-16 | $1.78M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$2.19M derived: sum of 2 quarters · filed 2020-10-29 | -$2.12M 10-Q · filed 2020-10-29 | $579.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | -$806.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$737.00K 10-Q · filed 2020-07-29 | $1.96M derived: sum of 3 quarters · filed 2021-02-11 | $3.64M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $69.00K 10-Q · filed 2020-04-29 | $2.77M derived: sum of 2 quarters · filed 2021-02-11 | $4.44M derived: sum of 3 quarters · filed 2021-02-11 | $6.95M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $4.38M derived: sum of 2 quarters · filed 2021-02-11 | $6.88M derived: sum of 3 quarters · filed 2021-02-11 | $5.99M 10-K · filed 2021-02-11 |
| 2018-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $4.18M derived: sum of 2 quarters · filed 2019-10-23 | $3.29M 10-Q · filed 2019-10-23 | $10.85M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $1.61M 10-Q · filed 2019-07-25 | $9.18M derived: sum of 3 quarters · filed 2020-02-13 | $5.55M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$890.00K 10-Q · filed 2019-04-25 | $6.67M derived: sum of 2 quarters · filed 2020-02-13 | $3.04M derived: sum of 3 quarters · filed 2020-02-13 | |
| 2017-12-31 | $7.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $3.93M derived: sum of 2 quarters · filed 2020-02-13 | $9.51M 10-K · filed 2020-02-13 | |
| 2017-09-30 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $1.94M 10-Q · filed 2018-10-23 | ||
| 2017-06-30 | $5.57M 10-Q · filed 2018-07-26 | |||
| 2016-12-31 | $15.01M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |